Skip to main content
# Title Research Year
111 Avermectin Derivatives, Pharmacokinetics, Therapeutic and Toxic Dosages, Mechanism of Action, and Their Biological Effects 2020
112 Impact of comorbidities on COVID-19 outcome 2020
113 Downregulation of B regulatory cells and upregulation of T helper
1 cells in children with Gaucher disease undergoing enzyme
replacement therapy
2020
114 Methicillin-Resistant Staphylococcus aureus (MRSA): One Health Perspective Approach to the Bacterium Epidemiology, Virulence Factors, Antibiotic-Resistance, and Zoonotic Impact 2020
115 Clinical and microbial characterization of toxigenic Clostridium difficile
isolated from antibiotic associated diarrhea in Egypt
2020
116 Circulation of hepatitis E virus (HEV) and/or HEV-like agent in non-mixed dairy farms could represent a potential source of infection for Egyptian people 2020
117 Enhancement of the Molecular and Serological Assessment of Hepatitis E Virus in Milk Samples
2020
118 Investigating Virological, Immunological, and Pathological Avenues to Identify Potential Targets for Developing COVID-19 Treatment and
Prevention Strategies
2020
119 IP-10 Levels in Patients Infected with HBV Predicts The Response to Treatment with Entecavir 2020
120 Impact of deranged B cell subsets distribution in the development of HCV‑related cirrhosis and HCC
in type two diabetes mellitus
2020